Transforming function of the HOX11/TCL3 homeobox gene.

The HOX11/TCL3 homeobox gene was identified at the breakpoint region in pediatric T-cell acute lymphoblastic leukemia harboring 10q24 chromosomal translocations. We previously reported that primary murine bone marrow cells transduced ex vivo with a recombinant HOX11-containing retrovirus, MSCV-HOX11, gave rise to cell lines at high frequency having characteristics of early myeloid cells. Cell lines were also established from the bone marrow and spleen of transplant recipients sacrificed 5 months after engraftment with MSCV-HOX11-transduced bone marrow cells. These latter lines, which exhibited a more differentiated myelomonocytic phenotype, harbored proviruses encoding a smaller HOX11 protein. None of the mice that received HOX11-expressing bone marrow cells or myeloid cell lines developed leukemia during 6-month observation periods. Here, we report that two bone marrow transplant recipients eventually developed T-cell acute lymphoblastic leukemia-like malignancies at 7 and 12 months posttransplant, indicating that progression to a fully malignant state required additional mutations. One tumor synthesized full-length HOX11 whereas the other expressed the smaller version of the protein. The smaller HOX11 protein suffered a carboxyl-terminal truncation. We subsequently constructed MSCV-based retroviral vectors expressing deleted forms of HOX11 and identified an amino-terminal region that was dispensible for generation of myeloid cell lines having a similar phenotype as those induced by full-length HOX11. We thus conclude that regions near the amino and carboxyl termini of HOX11 are not essential for transforming function, nor do they appear to determine the lineage or stage of differentiation of the target cell for transformation.

[1]  A. Ho,et al.  Three distinct domains in the HOX-11 homeobox oncoprotein are required for optimal transactivation. , 1996, Oncogene.

[2]  T. Reynolds,et al.  A novel murine retrovirus identified during testing for helper virus in human gene transfer trials , 1996, Journal of virology.

[3]  Takuro Nakamura,et al.  Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias , 1996, Nature Genetics.

[4]  U. Kees,et al.  HOX11 expression in pediatric acute lymphoblastic leukemia is associated with T-cell phenotype. , 1995, Oncogene.

[5]  T. Hawley,et al.  Hematopoietic transforming potential of activated ras in chimeric mice. , 1995, Oncogene.

[6]  I. Rambaldi,et al.  Cooperative interactions between HOX and PBX proteins mediated by a conserved peptide motif , 1995, Molecular and cellular biology.

[7]  Q. Lu,et al.  Both Pbx1 and E2A-Pbx1 bind the DNA motif ATCAATCAA cooperatively with the products of multiple murine Hox genes, some of which are themselves oncogenes , 1995, Molecular and cellular biology.

[8]  M. Cleary,et al.  Pbx proteins display hexapeptide-dependent cooperative DNA binding with a subset of Hox proteins. , 1995, Genes & development.

[9]  T. Rabbitts,et al.  Chromosomal translocations in human cancer , 1994, Nature.

[10]  M. Kamps,et al.  Oncoprotein E2A-Pbx1 immortalizes a myeloid progenitor in primary marrow cultures without abrogating its factor-dependence. , 1994, Oncogene.

[11]  J. Lust,et al.  Tyrosine phosphorylation of JAK-TYK kinases in malignant plasma cell lines growth-stimulated by interleukins 6 and 11. , 1994, Biochemical and biophysical research communications.

[12]  Tom Maniatis,et al.  Transcriptional activation: A complex puzzle with few easy pieces , 1994, Cell.

[13]  T. Hawley,et al.  The HOX11 homeobox-containing gene of human leukemia immortalizes murine hematopoietic precursors. , 1994, Oncogene.

[14]  E. Freireich,et al.  Joining of recombination signals on the der 14q- chromosome in T-cell acute leukemia with t(10;14) chromosome translocation. , 1994, Cancer research.

[15]  A. Perkins,et al.  Conditional immortalization of mouse myelomonocytic, megakaryocytic and mast cell progenitors by the Hox‐2.4 homeobox gene. , 1993, The EMBO journal.

[16]  D. Baltimore,et al.  E2A-Pbx1, the t(1;19) translocation protein of human pre-B-cell acute lymphocytic leukemia, causes acute myeloid leukemia in mice , 1993, Molecular and cellular biology.

[17]  A. Zlotnik,et al.  Phenotypic and functional characterization of c-kit expression during intrathymic T cell development. , 1992, Journal of immunology.

[18]  T. Hawley,et al.  Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus , 1992, The Journal of experimental medicine.

[19]  W. Shen,et al.  DMSO improves PCR amplification of DNA with complex secondary structure , 1992 .

[20]  I. Weissman,et al.  Lymphocyte development from stem cells. , 1992, Annual review of immunology.

[21]  S. Korsmeyer,et al.  Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes. , 1992, Annual review of immunology.

[22]  S. Kamel‐Reid,et al.  A novel human homeobox gene lies at the chromosome 10 breakpoint in lymphoid neoplasias with chromosomal translocation t(10;14) , 1991 .

[23]  M. Cleary,et al.  PBX2 and PBX3, new homeobox genes with extensive homology to the human proto-oncogene PBX1 , 1991, Molecular and cellular biology.

[24]  M. Lu,et al.  The tcl‐3 proto‐oncogene altered by chromosomal translocation in T‐cell leukemia codes for a homeobox protein. , 1991, The EMBO journal.

[25]  G. Schieven,et al.  Engagement of interleukin-7 receptor stimulates tyrosine phosphorylation, phosphoinositide turnover, and clonal proliferation of human T-lineage acute lymphoblastic leukemia cells. , 1991, Blood.

[26]  C. Fox,et al.  Cloning of a human homeobox gene that resembles a diverged Drosophila homeobox gene and is expressed in activated lymphocytes. , 1991, The New biologist.

[27]  A. Strasser,et al.  Novel murine homeo box gene on chromosome 1 expressed in specific hematopoietic lineages and during embryogenesis. , 1991, Genes & development.

[28]  T. Hawley,et al.  Leukocytosis in mice following long-term reconstitution with genetically-modified bone marrow cells constitutively expressing interleukin 1 alpha or interleukin 6. , 1991, Leukemia research.

[29]  T. Hawley,et al.  Establishment of a novel factor-dependent myeloid cell line from primary cultures of mouse bone marrow. , 1991, Cytokine.

[30]  E. Leonard,et al.  A multiwell cell settling and adherence chamber for morphology and differential counting. , 1990, BioTechniques.

[31]  T. Agthoven,et al.  Interleukin-7 is a growth factor of precursor B and T acute lymphoblastic leukemia. , 1990, Blood.

[32]  R. Boyd,et al.  The effects of interleukin 2 on early and late thymocyte differentiation in foetal thymus organ culture. , 1990, International immunology.

[33]  J. Garcia,et al.  Expression of human adenosine deaminase in mice after transplantation of genetically-modified bone marrow. , 1990, Blood.

[34]  David Baltimore,et al.  A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B all , 1990, Cell.

[35]  Michael L. Cleary,et al.  Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor , 1990, Cell.

[36]  M. Egerton,et al.  A murine early thymocyte developmental sequence is marked by transient expression of the interleukin 2 receptor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. M. Adams,et al.  Expression of multiple homeobox genes within diverse mammalian haemopoietic lineages. , 1988, The EMBO journal.

[38]  F. Dumont,et al.  N-terminal and cDNA characterization of murine lymphocyte antigen Ly-6C.2. , 1988, Journal of immunology.

[39]  H. Karasuyama,et al.  Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors , 1988, European journal of immunology.

[40]  H. Pircher,et al.  T cell receptor variable gene usage in a specific cytotoxic T cell response. Primary structure of the antigen-MHC receptor of four hapten- specific cytotoxic T cell clones , 1987, The Journal of experimental medicine.

[41]  M. McBurney,et al.  Cloning and expression of the mouse pgk-1 gene and the nucleotide sequence of its promoter. , 1987, Gene.

[42]  A. Tartakoff,et al.  Hydrophilic anchor-deficient Thy-1 is secreted by a class E mutant T lymphoma , 1986, Cell.

[43]  C. Yanisch-Perron,et al.  Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. , 1985, Gene.

[44]  R. Hawley,et al.  Transposition of two different intracisternal A particle elements into an immunoglobulin kappa-chain gene , 1984, Molecular and cellular biology.

[45]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[46]  C. Taylor,et al.  Experimental models of lymphoproliferative disease. The mouse as a model for human non-Hodgkin's lymphomas and related leukemias. , 1983, The American journal of pathology.

[47]  J. Ihle,et al.  Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, p cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity. , 1983, Journal of immunology.

[48]  B. Reiss,et al.  Nucleotide sequence and exact localization of the neomycin phosphotransferase gene from transposon Tn5. , 1982, Gene.

[49]  C. Gahmberg,et al.  Induction of erythroid differentiation in the human leukaemia cell line K562 , 1979, Nature.